LOS ANGELES CAPITAL MANAGEMENT LLC

Position in IOVA — Iovance Biotherapeutics, Inc.

CIK 1177206 LOS ANGELES, CA

Position in IOVA

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

$628,848

+$301,631 QoQ

Shares Held

179,159

+49.5% QoQ

Ownership

0.040%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 49.938322942191014.ToString("F0")% Shared 0.ToString("F0")% None 50.061677057808986.ToString("F0")%

Healthcare · as of Mar 31, 2026

LOS ANGELES CAPITAL MANAGEMENT LLC holds $690,033,476 across 153 Biotechnology names. IOVA ranks #41 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	2,144,847	$201,872,999
2	EXEL	Exelixis, Inc.	3,102,634	$133,071,972
3	REGN	Regeneron Pharmaceuticals, Inc.	78,880	$60,945,843
4	RPRX	Royalty Pharma plc	971,927	$46,623,338
5	HALO	Halozyme Therapeutics, Inc.	689,915	$44,589,206
6	CAI	Caris Life Sciences, Inc.	2,289,602	$40,938,083
7	ALNY	Alnylam Pharmaceuticals, Inc.	88,278	$29,208,541
8	VRTX	Vertex Pharmaceuticals Inc / Ma	64,937	$28,996,967

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$628,848	179,159	+49.5%	Shares	Sole	2026-05-08
2025-12-31	$327,217	119,860	+381.9%	Shares	Sole	2026-02-11
2025-09-30	$53,970	24,871	-34.0%	Shares	Sole	2025-10-20
2025-06-30	$64,766	37,655	+127.5%	Shares	Sole	2025-08-07
2025-03-31	$55,124	16,554	-73.2%	Shares	Sole	2025-05-05
2024-12-31	$457,016	61,759	0.0%	Shares	Sole	2025-02-04
2024-09-30	$579,917	61,759	+156.0%	Shares	Sole	2024-11-04
2024-06-30	$193,474	24,124	+228.9%	Shares	Sole	2024-08-05
2020-09-30	$241,468	7,335	-73.9%	Shares	Sole	2020-11-02
2020-06-30	$771,372	28,101	+26.3%	Shares	Sole	2020-08-05
2020-03-31	$666,045	22,246	—	Shares	Sole	2020-05-04
No filing history on record for this holder in this stock.